TheEdgeResearch
Home / Stocks / CTABF

Canntab Therapeutics Limited (CTABF)

OTC Healthcare Drug Manufacturers - Specialty & Generic
$0.00 ▲ +0.00%
Market Cap
$3,891
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Beta
1.42
52-Wk Range
0.0001-0.0073
CEO
Richard C. Goldstein
Country
CA
Currency
USD

Canntab Therapeutics Limited operates in the Drug Manufacturers - Specialty & Generic industry of the Healthcare sector, headquartered in Markham, ON, CA. The stock last traded at $0.00, up 0.00% on the session, giving a market capitalisation of $3,891. On trailing twelve-month figures it carries a trailing P/E of -0.00, a net margin of -1257.6%. Its beta of 1.42 implies it has historically moved more than the broad market.

Valuation & profitability (TTM)
P/E
-0.00
Price / Sales
0.02
Price / Book
-0.02
EV / EBITDA
-0.46
Gross margin
-320.1%
Operating margin
-1419.4%
Net margin
-1257.6%
Return on equity
—
Debt / equity
-5.91
Current ratio
0.57
Dividend yield
0.0%
Payout ratio
0.0%
Company profile
Exchange
Other OTC
Employees
—
IPO date
2017-11-28
Headquarters
Markham, ON, CA
About Canntab Therapeutics Limited

Canntab Therapeutics Limited, a phytopharmaceutical firm with its main office in Markham, Canada, is dedicated to the research and development of sophisticated, medical-grade cannabinoid compounds. The company's diverse portfolio within Canada includes various orally administered pharmaceutical cannabis products. These innovative dosage forms encompass extended-release cannabinoid pellets, rapid-onset cannabidiol options, multi-layered modified-release formulations, quickly dissolving flash-melt versions, and dual-layer cannabinoid tablets. Canntab's products are designed to address a wide spectrum of health concerns, such as sleep disturbances, post-traumatic stress disorder, social anxiety, different forms of addiction, arthritic conditions, general pain management, alleviating pain and stimulating appetite for cancer patients, and aiding in recovery from opioid and other painkiller dependencies.

Comparable companies

Canntab Therapeutics Limited is most often compared with the following Healthcare names:

CNGGFCPIVFLIFDNRPRRNVARPNRFRVVTFSTHZFTGIFFTNRG
More research on CTABF
CTABF technical analysis CTABF TheEdge Score Compare against peers
Open full interactive analysis & DCF →